January 9, 2025 - 17:10

In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
June 19, 2026 - 04:27
Technology will continue to drive the ‘roaring 2020s’ to the end of the decade: Ed YardeniEd Yardeni, president of Yardeni Research, argues that the current economic expansion, which he calls the `roaring 2020s,` still has plenty of fuel left thanks to rapid advances in technology....
June 18, 2026 - 03:54
NZX Midday Sector Update: Technology Services Advance, Consumer Durables FallTechnology services shares posted the strongest gains on New Zealand`s Exchange by midday Thursday, climbing nearly 2% as investors rotated into the sector. The advance pushed the broader market...
June 17, 2026 - 18:32
4 Technologies Chasing Quantum Computing Supremacy and the Stocks to Invest In With EachThe race to build a practical quantum computer is not a single contest but several parallel ones. Researchers are pursuing at least four distinct physical technologies to create stable qubits, the...
June 17, 2026 - 02:03
Patchwork Tech Upgrades Risk Creating 'Architected Disadvantage'Organizations racing to modernize their technology stacks often end up building the next generation of legacy systems without realizing it. When upgrades happen in isolated chunks rather than as...